FDAnews
www.fdanews.com/articles/81491-reckitt-benckiser-to-buy-otc-unit

RECKITT BENCKISER TO BUY OTC UNIT

October 7, 2005

Household products group Reckitt Benckiser on Friday won an auction to buy Boots Group's over-the-counter drugs unit, Boots Healthcare International, for 1.93 billion pounds ($3.42 billion) in cash. Reckitt Benckiser (UK:RB: news, chart, profile) won an auction that included GlaxoSmithKline (GSK: news, chart, profile) and Bayer (BAY: news, chart, profile) for the unit that makes Nurofen, the world's second-most popular Ibuprofen brand; Strepsils, the world's top sore throat medication; and the Clearasil anti-acne drug.

Market Watch (http://www.marketwatch.com/news/yhoo/story.asp?source=blq/yhoo&siteid=yhoo&dist=yhoo&guid=%7B5055264C%2DD798%2D4E77%2DA3A9%2DA753D807D307%7D)